middle.news

Orthocell Targets $750M EU-UK Nerve Repair Market with Remplir™ Application

9:15am on Monday 15th of December, 2025 AEDT Healthcare
Read Story

Orthocell Targets $750M EU-UK Nerve Repair Market with Remplir™ Application

9:15am on Monday 15th of December, 2025 AEDT
Key Points
  • Regulatory submission to British Standards Institution for CE and UKCA certification
  • Targeting $750 million EU and UK nerve repair market with 500,000 annual procedures
  • Real-world evidence shows 81.1% treatment success rate for Remplir™
  • Go-to-market strategy includes specialist distributors and surgeon Key Opinion Leaders
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Orthocell (ASX:OCC)
OPEN ARTICLE